| High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year … SW Syversen, PI Gaarder, GL Goll, S Ødegård, EA Haavardsholm, ... Annals of the rheumatic diseases 67 (2), 212-217, 2008 | 378 | 2008 |
| Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study SW Syversen, GL Goll, D van der Heijde, R Landewé, BA Lie, S Ødegård, ... Annals of the rheumatic diseases 69 (2), 345-351, 2010 | 207 | 2010 |
| Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up M Hoff, G Haugeberg, S Ødegård, S Syversen, R Landewé, ... Annals of the rheumatic diseases 68 (3), 324-329, 2009 | 145 | 2009 |
| Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis HB Hammer, S Ødegård, SW Syversen, R Landewé, D van der Heijde, ... Annals of the rheumatic diseases 69 (01), 150-154, 2010 | 141 | 2010 |
| Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study I Jyssum, H Kared, TT Tran, AT Tveter, SA Provan, J Sexton, ... The Lancet Rheumatology 4 (3), e177-e187, 2022 | 140 | 2022 |
| Effect of therapeutic drug monitoring vs standard therapy during infliximab induction on disease remission in patients with chronic immune-mediated inflammatory diseases: a … SW Syversen, GL Goll, KK Jørgensen, Ø Sandanger, J Sexton, IC Olsen, ... Jama 325 (17), 1744-1754, 2021 | 113 | 2021 |
| The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis D van der Woude, SW Syversen, EIH van der Voort, KN Verpoort, GL Goll, ... Annals of the rheumatic diseases 69 (6), 1110-1116, 2010 | 107 | 2010 |
| Effect of therapeutic drug monitoring vs standard therapy during maintenance infliximab therapy on disease control in patients with immune-mediated inflammatory diseases: a … SW Syversen, KK Jørgensen, GL Goll, MK Brun, Ø Sandanger, ... Jama 326 (23), 2375-2384, 2021 | 106 | 2021 |
| Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression SW Syversen, GL Goll, D van der HEIJDE, R Landewe, PI Gaarder, ... The Journal of rheumatology 36 (2), 266-272, 2009 | 90 | 2009 |
| Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and … WP Maksymowych, R Landewé, PP Tak, CJ Ritchlin, M Østergaard, ... The Journal of Rheumatology 36 (8), 1785-1791, 2009 | 59 | 2009 |
| Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis HU Scherer, D van der Woude, A Willemze, LA Trouw, R Knevel, ... Annals of the rheumatic diseases 70 (8), 1461-1464, 2011 | 57 | 2011 |
| Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs SW Syversen, EA Haavardsholm, P Bøyesen, GL Goll, C Okkenhaug, ... Annals of the rheumatic diseases 69 (5), 845-850, 2010 | 56 | 2010 |
| Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing … WP Maksymowych, O Fitzgerald, GA Wells, DD Gladman, R Landewé, ... The Journal of Rheumatology 36 (8), 1792-1799, 2009 | 55 | 2009 |
| A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients SW Syversen, GL Goll, EA Haavardsholm, P Bøyesen, T Lea, TK Kvien Arthritis research & therapy 10, 1-4, 2008 | 51 | 2008 |
| Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study P Bøyesen, M Hoff, S Ødegård, G Haugeberg, SW Syversen, PI Gaarder, ... Arthritis research & therapy 11, 1-9, 2009 | 50 | 2009 |
| Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy SW Syversen, I Jyssum, AT Tveter, TT Tran, J Sexton, SA Provan, ... Arthritis & Rheumatology 74 (8), 1321-1332, 2022 | 44 | 2022 |
| EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases CLM Krieckaert, A van Tubergen, JE Gehin, B Hernández-Breijo, ... Annals of the rheumatic diseases 82 (1), 65-73, 2023 | 41 | 2023 |
| Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis B Grandaunet, SW Syversen, M Hoff, A Sundan, G Haugeberg, ... Arthritis & Rheumatism 63 (3), 662-669, 2011 | 38 | 2011 |
| Proactive therapeutic drug monitoring versus conventional management for inflammatory bowel diseases: a systematic review and meta-analysis NH Nguyen, V Solitano, SK Vuyyuru, JK MacDonald, SW Syversen, ... Gastroenterology 163 (4), 937-949. e2, 2022 | 35 | 2022 |
| Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV … SW Syversen, GL Goll, KK Jørgensen, IC Olsen, Ø Sandanger, JE Gehin, ... Trials 21, 1-14, 2020 | 34 | 2020 |
